BioMarin Pharmaceutical Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue766.2M874.6M776.1M825.4M745.1M747.3M745.7M712.0M
Cost of Goods Sold195.0M295.1M140.1M150.1M151.6M136.1M188.5M130.5M
Gross Profit571.2M579.5M636.0M675.3M593.6M611.2M557.3M581.6M
R&D Expenses178.8M192.4M409.5M161.3M158.7M173.5M184.9M183.8M
Operating Expenses441.6M500.1M682.7M398.4M369.7M449.8M443.4M461.1M
Operating Income129.6M79.4M-46.7M276.9M223.9M161.4M113.9M120.5M
Other Income / Gains11.6M-106.5M20.4M21.0M14.2M8.2M20.5M11.7M
Net Income105.5M-46.6M-30.7M240.5M185.7M124.9M106.1M107.2M
EPS (Diluted)0.55-0.24-0.161.250.970.660.570.56
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.7460.6630.820.8180.7970.8180.7470.817
General And Administrative Expenses133.4M802.1M137.1M110.2M103.6M141.0M144.6M140.2M
Selling And Marketing Expenses124.9M0131.3M122.1M102.5M125.6M108.9M122.8M
Selling General And Administrative Expenses258.3M802.1M268.4M232.3M206.1M266.6M253.5M263.0M
Other Expenses4.5M-494.4M4.8M4.8M4.9M9.7M5.0M14.3M
Cost And Expenses636.6M795.2M822.8M548.5M521.3M585.9M631.8M591.6M
Interest Income22.6M19.2M17.9M18.8M19.0M17.7M18.1M19.8M
Interest Expense15.0M2.8M2.6M2.7M2.9M2.6M3.0M3.6M
Depreciation And Amortization16.4M20.4M18.5M18.6M22.1M23.6M19.0M26.5M
Ebitda172.6M-3.9M-5.3M319.1M263.0M195.5M156.4M162.2M
Ebitdaratio0.225-0.005-0.0070.3870.3530.2620.210.228
Operating Income Ratio0.1690.091-0.060.3350.300.2160.1530.169
Income Before Tax141.2M-27.2M-26.3M297.9M238.1M169.6M134.4M132.1M
Income Before Tax Ratio0.184-0.031-0.0340.3610.320.2270.180.186
Income Tax Expense35.7M19.4M4.4M57.3M52.4M44.7M28.4M25.0M
Net Income Ratio0.138-0.053-0.040.2910.2490.1670.1420.151
Epsdiluted0.54-0.22-0.161.230.950.640.550.55
Weighted Average Shs Out192.5M191.8M192.0M191.4M191.0M190.7M190.4M190.1M
Weighted Average Shs Out Dil197.7M197.4M192.0M196.6M196.5M196.6M197.1M200.5M